How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

We finish off our short series on SLM optimization with the third entry, focused on batching by length instead of looping ...

AI is rewriting the world and, at the same time, inventing a whole new language to describe how it’s doing it. Sit in on any product meeting, pitch, or panel these days, and you’ll hear people toss ...

Over the past week, a global reckoning about the risks of artificial intelligence spread from the frontier labs of Silicon Valley to living rooms across America and the corridors of power in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals reported 5 insider transactions totaling $528,153.30. Activity split between 3 Tax Payments worth $351,830.92 and 2 Sales worth $176,322.38. Ben R Taylor and Najat Khan ...